nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease
|
Martin, Paul J. |
|
|
130 |
3 |
p. 360-367 |
artikel |
2 |
A new therapeutic strategy for atypical HUS
|
Moake, Joel L. |
|
|
130 |
3 |
p. 243-244 |
artikel |
3 |
Angiotensin-converting enzyme enhances the oxidative response and bactericidal activity of neutrophils
|
Khan, Zakir |
|
|
130 |
3 |
p. 328-339 |
artikel |
4 |
Can histologic transformation of follicular lymphoma be predicted and prevented?
|
Kridel, Robert |
|
|
130 |
3 |
p. 258-266 |
artikel |
5 |
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies
|
Gomes-Silva, Diogo |
|
|
130 |
3 |
p. 285-296 |
artikel |
6 |
CD27 marks murine embryonic hematopoietic stem cells and type II prehematopoietic stem cells
|
Li, Yan |
|
|
130 |
3 |
p. 372-376 |
artikel |
7 |
CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies
|
Al Sayed, Mohamad F. |
|
|
130 |
3 |
p. 297-309 |
artikel |
8 |
CD70 turns on NK cells to attack lymphoma
|
Fehniger, Todd A. |
|
|
130 |
3 |
p. 238-239 |
artikel |
9 |
Check this checkpoint inhibitor in lymphoma
|
Cabanillas, Fernando |
|
|
130 |
3 |
p. 234-235 |
artikel |
10 |
Choosing wisely: RUNX1 alternate promoter use
|
Cantor, Alan B. |
|
|
130 |
3 |
p. 236-237 |
artikel |
11 |
Classical Hodgkin lymphoma and Castleman disease: a rare morphologic combination
|
Gong, Shunyou |
|
|
130 |
3 |
p. 381 |
artikel |
12 |
Curtis C, Mineyko A, Massicotte P, et al. Thrombophilia risk is not increased in children after perinatal stroke. Blood. 2017;129(20):2793-2800.
|
|
|
|
130 |
3 |
p. 382 |
artikel |
13 |
Eculizumab cessation in atypical hemolytic uremic syndrome
|
Merrill, Samuel A. |
|
|
130 |
3 |
p. 368-372 |
artikel |
14 |
Editorial Board
|
|
|
|
130 |
3 |
p. i |
artikel |
15 |
Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non–transferrin-bound iron
|
Stefanova, Deborah |
|
|
130 |
3 |
p. 245-257 |
artikel |
16 |
Ironing out the role of hepcidin in infection
|
Prchal, Josef T. |
|
|
130 |
3 |
p. 233-234 |
artikel |
17 |
Might broader be better?
|
Johnson, Amy J. |
|
|
130 |
3 |
p. 239-240 |
artikel |
18 |
Mouse RUNX1C regulates premegakaryocytic/erythroid output and maintains survival of megakaryocyte progenitors
|
Draper, Julia E. |
|
|
130 |
3 |
p. 271-284 |
artikel |
19 |
Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation
|
Schmidt, Janine |
|
|
130 |
3 |
p. 323-327 |
artikel |
20 |
NF-κB p50 (nfkb1) contributes to pathogenesis in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia
|
Chen, Timothy L. |
|
|
130 |
3 |
p. 376-379 |
artikel |
21 |
Noninvasive detection of F8 int22h-related inversions and sequence variants in maternal plasma of hemophilia carriers
|
Hudecova, Irena |
|
|
130 |
3 |
p. 340-347 |
artikel |
22 |
Peripheral eosinophilia as the first manifestation of B-cell acute lymphoblastic leukemia with t(5;14)(q31;q32)
|
Toboso, Dolores Gómez |
|
|
130 |
3 |
p. 380 |
artikel |
23 |
Predicting transformation of follicular lymphoma
|
|
|
|
130 |
3 |
p. 383 |
artikel |
24 |
Prenatal diagnosis by droplet digital PCR
|
Ragni, Margaret V. |
|
|
130 |
3 |
p. 240-241 |
artikel |
25 |
Raising the bar for chronic GVHD trials
|
Kröger, Nicolaus |
|
|
130 |
3 |
p. 241-242 |
artikel |
26 |
Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma
|
Zinzani, Pier Luigi |
|
|
130 |
3 |
p. 267-270 |
artikel |
27 |
Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCL
|
Erdmann, Tabea |
|
|
130 |
3 |
p. 310-322 |
artikel |
28 |
T-cell expression of AhR inhibits the maintenance of pTreg cells in the gastrointestinal tract in acute GVHD
|
Dant, Trisha A. |
|
|
130 |
3 |
p. 348-359 |
artikel |